- Home
- LGND vs FRPT Comparison
LGND vs FRPT Comparison
Compare LGND & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGND | FRPT |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | LGND | FRPT |
|---|---|---|
| Price | $195.24 | $55.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 17 |
| Target Price | ★ $245.86 | $79.47 |
| AVG Volume (30 Days) | 183.6K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 183.87 |
| EPS | N/A | ★ 2.64 |
| Revenue | N/A | ★ $1,102,015,000.00 |
| Revenue This Year | $1.50 | $11.34 |
| Revenue Next Year | $18.28 | $9.21 |
| P/E Ratio | $76.27 | ★ $22.30 |
| Revenue Growth | N/A | ★ 13.01 |
| 52 Week Low | $93.58 | $46.76 |
| 52 Week High | $227.92 | $89.80 |
Technical Indicators
Market Signals| Indicator | LGND | FRPT |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 23.66 |
| Support Level | $179.55 | $48.93 |
| Resistance Level | $207.72 | $56.73 |
| Average True Range (ATR) | 10.02 | 4.40 |
| MACD | -1.59 | -2.31 |
| Stochastic Oscillator | 3.39 | 11.50 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.